EPI 200
Alternative Names: EPI-200Latest Information Update: 08 Sep 2023
At a glance
- Originator CervoMed
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical CNS disorders
Most Recent Events
- 25 Aug 2023 CervoMed pipeline August 2023: New profile created
- 21 Aug 2023 Preclinical trials in CNS disorders in USA (unspecified route) (CervoMed pipeline August 2023)